AR043731A1 - Nuevo metodo para producir un forma solida de heparina - Google Patents

Nuevo metodo para producir un forma solida de heparina

Info

Publication number
AR043731A1
AR043731A1 ARP040100707A ARP040100707A AR043731A1 AR 043731 A1 AR043731 A1 AR 043731A1 AR P040100707 A ARP040100707 A AR P040100707A AR P040100707 A ARP040100707 A AR P040100707A AR 043731 A1 AR043731 A1 AR 043731A1
Authority
AR
Argentina
Prior art keywords
solid form
new method
heparin
heparine
produce
Prior art date
Application number
ARP040100707A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of AR043731A1 publication Critical patent/AR043731A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/10—Heparin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/14—Powdering or granulating by precipitation from solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/10—Heparin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
ARP040100707A 2003-03-07 2004-03-05 Nuevo metodo para producir un forma solida de heparina AR043731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45270103P 2003-03-07 2003-03-07

Publications (1)

Publication Number Publication Date
AR043731A1 true AR043731A1 (es) 2005-08-10

Family

ID=32962743

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100707A AR043731A1 (es) 2003-03-07 2004-03-05 Nuevo metodo para producir un forma solida de heparina

Country Status (12)

Country Link
US (1) US6933372B2 (enExample)
EP (1) EP1611161B1 (enExample)
JP (1) JP2006519906A (enExample)
AR (1) AR043731A1 (enExample)
AT (1) ATE368057T1 (enExample)
CA (1) CA2517141C (enExample)
CL (1) CL2004000414A1 (enExample)
DE (1) DE602004007784T2 (enExample)
ES (1) ES2289492T3 (enExample)
MX (1) MXPA05009498A (enExample)
TW (1) TWI274761B (enExample)
WO (1) WO2004078791A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CN101575385B (zh) * 2008-05-09 2011-01-12 青岛九龙生物医药有限公司 萃取法分离肝素钠中的多硫酸软骨素的方法
CN101831008B (zh) * 2009-03-11 2013-04-10 四川茂森生物科技有限公司 粗品肝素钠精制生产新工艺
CN108508129B (zh) * 2018-04-03 2020-11-27 青岛海洋生物医药研究院股份有限公司 一种肝素类药物生物效价的测定方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2034599A (en) 1933-07-10 1936-03-17 Buffalo Foundry & Machine Co Method of drying inorganic salts and sludges
US2571679A (en) 1948-07-08 1951-10-16 Carlo Erba S A Process for preparing purified heparin
US2797184A (en) 1953-07-01 1957-06-25 Upjohn Co Process for the recovery of heparin
US2884358A (en) 1957-04-22 1959-04-28 Southern California Gland Co Process for preparing crude heparin
US2954321A (en) 1957-09-23 1960-09-27 Upjohn Co Process for preparing heparin
US3337409A (en) 1963-11-20 1967-08-22 Rexall Drug Chemical Process for the recovery of heparin
US3330327A (en) * 1964-03-30 1967-07-11 Continental Oil Co Drying tertiary amine oxides on extended heated surfaces at elevated temperatures
US3817831A (en) 1973-01-10 1974-06-18 Wilson Pharm & Chem Corp Process for production of alkali metal salt of heparin
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4510135A (en) * 1982-04-21 1985-04-09 Research Corporation Orally administered heparin
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
DK170015B1 (da) * 1992-03-19 1995-05-01 Sudurnesja Hitaveita Saltprodukt samt fremgangsmåde til dets fremstilling
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
DE4310088A1 (de) 1993-03-27 1994-09-29 Hoechst Ag Verfahren zur Herstellung und Aufarbeitung von in wäßrigem Medium löslichen N-Hydroxyalkylchitosanen
AU682792B2 (en) * 1994-10-13 1997-10-16 Cv Therapeutics, Inc. Method of manufacturing non-absorbable synthetic sulfated polysaccharides
CA2173642C (en) * 1995-04-10 1999-11-02 James Vincent Gruber Process for derivatizing polyglucosamines
TR200000086T2 (tr) 1997-07-16 2000-08-21 Akzo Nobel N.V. Heparin üretimi için işlem.
CN1218058A (zh) 1997-11-26 1999-06-02 中国林业科学研究院林产化学工业研究所 肝素的喷雾干燥方法
US6485945B1 (en) 1999-02-17 2002-11-26 Nurture, Inc. Polysaccharide compositions and uses thereof
AU3623601A (en) 2000-02-07 2001-08-14 Granate Seed Ltd Process for extraction of beta-glucan from cereals and products obtained therefrom

Also Published As

Publication number Publication date
TWI274761B (en) 2007-03-01
EP1611161B1 (en) 2007-07-25
ATE368057T1 (de) 2007-08-15
US20040176581A1 (en) 2004-09-09
ES2289492T3 (es) 2008-02-01
DE602004007784T2 (de) 2007-12-06
EP1611161A1 (en) 2006-01-04
US6933372B2 (en) 2005-08-23
CA2517141C (en) 2008-11-18
MXPA05009498A (es) 2005-10-18
WO2004078791A1 (en) 2004-09-16
TW200502255A (en) 2005-01-16
CL2004000414A1 (es) 2005-02-04
JP2006519906A (ja) 2006-08-31
CA2517141A1 (en) 2004-09-16
DE602004007784D1 (de) 2007-09-06

Similar Documents

Publication Publication Date Title
FR2894136B1 (fr) Article cosmetique soluble moussant
AR067775A1 (es) (2s,3r)-n-(2-((3- piridinil) metil)-1- azabiciclo (2.2.2= oct-3-il) benzofuran -2- carboxamida, formas de sales y metodos de uso
AR060929A1 (es) Articulos, peliculas y metodos para envasado que promueven o conservan el color deseado de la carne
ECSP088352A (es) Derivados de indol 1,3-disustituido para su uso como moduladores de ppar
MX363714B (es) Aparato y metodo de secado mejorados.
ECSP077271A (es) Derivados de pirimidina
ECSP077259A (es) Derivados de pirimidina
CL2011000462A1 (es) Composicion de aceite que contiene aceite y caldo, en que la proporcion de aceite a caldo varia desde 1:1 hasta 1:3; metodo de preparacion de dicha composicion; uso de dicha composicion; y metodo para la preparacion de productos a base de carne que contienen aceite.
GT200500257AA (es) Procedimiento para producir derivados de amina opticamente activos
CR11643A (es) Metodo y aparato para desecar una mezcla de etanol y agua
DE60221029D1 (de) Gewebe für industrielle verfahren
AR056293A1 (es) Una composicion para extraccion con solventes y proceso para la extraccion de un metal en solucion.
CL2024001227A1 (es) Proceso para usar una composición de secado de solvente para recuperar agua de solvente
AR043731A1 (es) Nuevo metodo para producir un forma solida de heparina
DK1289629T3 (da) Mikrofiltrering under anvendelse af aktivt kul
ATE529712T1 (de) Verfahren zur herstellung von trockenen freifliessenden hydrophobinzubereitungen
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
CY1108916T1 (el) Υποκαθιστουμενες πυρρολες, οι ενωσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση τους
AR051341A1 (es) Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina
MX244558B (es) Proceso para preparar benzotriazoles.
CY1105012T1 (el) Επικαλυψη, διαδικασια παρασκευης και χρηση της σε τεμαχια απο ξυλο
ATE448885T1 (de) Vorrichtung zur oberflächenbeschichtung von kleinteilen
UY29914A1 (es) Uso de piraclostrobina como asegurador para triticonazol para combatir hongos nocivos
ITMI20020907A1 (it) Processo di preparazione della forma amorfa del sale di calcio della atorvastatina
BRPI0500773A (pt) método para secagem de neotame com um co-agente para proporcionar um produto sólido contendo neotame, e, produto sólido contendo neotame possuindo uniformidade melhorada e estabilidade melhorada

Legal Events

Date Code Title Description
FG Grant, registration